L-dopa plasma levels and executive functions in Parkinson's disease

被引：0
|
作者：
Albani, G.
Cattaldo, S.
Mori, I.
Pignatti, R.
Pradotto, L.
Mauro, A.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [1] L-Dopa plasma levels variability in Parkinson's disease
    Albani, G.
    Cattaldo, S.
    Mauro, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S118
  • [2] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [3] Effect of L-dopa on plasma homocysteine in elderly patients with Parkinson' s disease
    王红梅
    [J]. China Medical Abstracts (Internal Medicine), 2006, (04) : 227 - 228
  • [4] Plasma lipid peroxidation in sporadic Parkinson's disease: Role of the l-dopa
    Morales, B.
    Salvatierra, J.
    Vives, F.
    Duran, R.
    Barrero, F.
    Agil, A.
    Alba, F.
    Martin, M.
    Peinado, J. M.
    Iribar, M. C.
    Ramirez, M.
    Giner, P.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S477 - S477
  • [5] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    [J]. Amino Acids, 2005, 28 : 157 - 164
  • [6] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    [J]. PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [7] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [8] The effect of L-dopa on speech in Parkinson's disease
    Skodda, S.
    Schlegel, U.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 233 - 233
  • [9] Focusing Effects of L-Dopa in Parkinson's Disease
    Ng, Bernard
    Palmer, Samantha
    Abugharbieh, Rafeef
    McKeown, Martin J.
    [J]. HUMAN BRAIN MAPPING, 2010, 31 (01) : 88 - 97
  • [10] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    [J]. AMINO ACIDS, 2005, 28 (02) : 157 - 164
12345